THE LEISHMANIA-DONOVANI LIPOPHOSPHOGLYCAN LYMPHOCYTE-T-REACTIVE COMPONENT IS A TIGHTLY ASSOCIATED PROTEIN COMPLEX

被引:0
作者
JARDIM, A
TOLSON, DL
TURCO, SJ
PEARSON, TW
OLAFSON, RW
机构
[1] UNIV VICTORIA,DEPT BIOCHEM & MICROBIOL,VICTORIA V8W 3P6,BC,CANADA
[2] UNIV KENTUCKY,DEPT BIOCHEM,LEXINGTON,KY 40536
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Lymphocytes from mice immunized with Leishmania donovani (LPG) were specifically stimulated to proliferate in vitro by purified LPG or its delipidated congener, phosphoglycan. The response was dose dependent and required prior immunization with either LPG or phosphoglycan. Proliferation was eliminated by specific depletion of Thy-1+ cells with antisera and C and the proliferating T cell subset was shown to be CD4+CD8-. Tests of various LPG fragments indicated that the T cell stimulation was associated with the core structure of LPG rather than the lipid or phosphoglycan repeat structure. However, amino acid analysis of LPG and active LPG fragments, after acid hydrolysis, showed the presence of amino acids in peptide linkage. Specific hydrolysis of the glycosidic linkages in LPG with trifluoromethanesulfonic acid provided polypeptide material reactive with two mAb previously believed to be LPG carbohydrate core specific. The protein was separated from LPG by reverse phase chromatography and shown to be a complex of proteins with common epitopes recognized by the two mAb. The dominant species isolated from LPG was a set of small, approximately 11,000 M(r), molecules. Subsequent T cell proliferation studies showed that the lymphocyte stimulation was associated with the protein component of LPG and not the glycan.
引用
收藏
页码:3538 / 3544
页数:7
相关论文
共 24 条
  • [1] BEELEY JG, 1985, LABORATORY TECHNIQUE, P100
  • [2] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [3] EDGE AS, 1981, BIOCHEMISTRY-US, V18, P131
  • [4] IMMUNIZATION WITH LEISHMANIA RECEPTOR FOR MACROPHAGES PROTECTS MICE AGAINST CUTANEOUS LEISHMANIASIS
    HANDMAN, E
    MITCHELL, GF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (17) : 5910 - 5914
  • [5] JAFFE CL, 1990, CLIN EXP IMMUNOL, V80, P77, DOI 10.1111/j.1365-2249.1990.tb06444.x
  • [6] IMMUNOPROTECTIVE LEISHMANIA-MAJOR SYNTHETIC T-CELL EPITOPES
    JARDIM, A
    ALEXANDER, J
    TEH, HS
    OU, D
    OLAFSON, RW
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (02) : 645 - 648
  • [7] ACTIVATION OF HUMAN LYMPHOCYTES-T BY LEISHMANIA LIPOPHOSPHOGLYCAN
    KEMP, M
    THEANDER, TG
    HANDMAN, E
    HEY, AS
    KURTZHALS, JAL
    HVIID, L
    SORENSEN, AL
    WERE, JOB
    KOECH, DK
    KHARAZMI, A
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1991, 33 (02) : 219 - 224
  • [8] CLEAVAGE OF STRUCTURAL PROTEINS DURING ASSEMBLY OF HEAD OF BACTERIOPHAGE-T4
    LAEMMLI, UK
    [J]. NATURE, 1970, 227 (5259) : 680 - +
  • [9] MURINE CUTANEOUS LEISHMANIASIS - SUSCEPTIBILITY CORRELATES WITH DIFFERENTIAL EXPANSION OF HELPER T-CELL SUBSETS
    LOCKSLEY, RM
    HEINZEL, FP
    SADICK, MD
    HOLADAY, BJ
    GARDNER, KD
    [J]. ANNALES DE L INSTITUT PASTEUR-IMMUNOLOGY, 1987, 138 (05): : 744 - 749
  • [10] LIPOPHOSPHOGLYCAN OF LEISHMANIA-MAJOR THAT VACCINATES AGAINST CUTANEOUS LEISHMANIASIS CONTAINS AN ALKYLGLYCEROPHOSPHOINOSITOL LIPID ANCHOR
    MCCONVILLE, MJ
    BACIC, A
    MITCHELL, GF
    HANDMAN, E
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (24) : 8941 - 8945